Ibrance 125 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F91UC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,666
Award facts
- Contract value 100% obligated
- $25,665.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $25,665.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count) on December 16, 2025, with completion targeted for January 8, 2026. This non-competitive, non-set-aside award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that serves as the company's primary contracting mechanism for federal medical procurement. The order will be fulfilled from AmerisourceBergen's distribution facilities in Conshohocken, Pennsylvania.
This delivery order supports the Defense Health Agency and related military healthcare systems with Ibrance, a critical oncology medication used in cancer treatment. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant federal contracting capacity across multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies. As a child contract under the broader SPE2DX IDC, this order exemplifies the DLA's strategy of leveraging prime vendor agreements to ensure reliable, competitively-awarded pharmaceutical supply chains that support military and veteran healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F91UC?
SPE2DR26F91UC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F91UC worth?
The government has obligated $25,666 on SPE2DR26F91UC.
Is contract SPE2DR26F91UC an order under another contract?
Yes. SPE2DR26F91UC is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91UC competed?
The extent of competition for SPE2DR26F91UC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award